Q-omics provides the consensus-scored TULP3P1 profile across patient tissues and cancer cell-line models. TULP3P1 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, TULP3P1 is differentially expressed in 3, with the highest sampling consensus in PAAD. Additionally, TULP3P1 RNA expression shows 6,025 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UVM, PAAD, and STAD as cancer lineages where TULP3P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TULP3P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TULP3P1 survival associations across molecular data types. TULP3P1 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TULP3P1 RNA expression–survival associations across cancer types. High TULP3P1 expression shows unfavorable associations in UVM, KIRC, LIHC, PAAD, KICH and LUSC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for TULP3P1 RNA expression.
This table summarizes TULP3P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for TULP3P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TULP3P1 shows lower tumor expression in PAAD and higher tumor expression in THCA and LUSC. The PAAD box plot shows higher TULP3P1 RNA expression in normal versus tumor tissue (log2 FC = −0.110, t-test p = .008).
This table shows molecular features associated with TULP3P1 in patient tissues and cancer cell lines. In patient samples, TULP3P1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
